Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2020-03-12 2020-03-12
Drug Identification Number 02438704 02438704
Brand name LORAZEPAM INJECTION USP LORAZEPAM INJECTION USP
Common or Proper name LORAZEPAM LORAZEPAM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1ml x 1 vial 1ml x 1 vial
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2020-02-14 2020-02-14
Remaining supply date 2020-12-31 2020-12-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments unforeseeable supply issue unforeseeable supply issue
Health Canada comments